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Endophytes are an endosymbiotic group of microorganisms that colonize in plants and
microbes that can be readily isolated from any microbial or plant growth medium. They
act as reservoirs of novel bioactive secondary metabolites, such as alkaloids, phenolic
acids, quinones, steroids, saponins, tannins, and terpenoids that serve as a potential
candidate for antimicrobial, anti-insect, anticancer and many more properties. While
plant sources are being extensively explored for new chemical entities for therapeutic
purposes, endophytic microbes also constitute an important source for drug discovery.
This review aims to comprehend the contribution and uses of endophytes as an
impending source of drugs against various forms of diseases and other possible
medicinal use.
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INTRODUCTION
Plants have served as a source of medicinal bioactive compounds against numerous forms of
ailments for centuries. Ironically, in recent years, microorganisms associated with plants rather
than plants themselves have proved to offer material and products with high therapeutic potential
(Subbulakshmi et al., 2012). Endophytes are an endosymbiotic group of microorganisms – often
bacteria or fungi – that colonize the inter- and/or intracellular locations of plants (Pimentel et al.,
2011; Singh and Dubey, 2015). For these organisms, all or part of their life cycle occurs within
their hosts, without causing any apparent symptoms of disease. They are ubiquitous in nature and
exhibit complex interactions with their hosts, which involve mutualism, antagonism and rarely
parasitism (Nair and Padmavathy, 2014). Endophytes are known to enhance host growth and
nutrient gain. They may improve the plant’s ability to tolerate various types of abiotic and biotic
stresses, and enhance the resistance of plants to insects and pests. They produce phytohormones
and other bioactive compounds of biotechnological interest (enzymes and pharmaceutical drugs)
(Joseph and Priya, 2011; Parthasarathi et al., 2012).
Researchers have indicated the presence of one or more types of endophytes in every single plant
studied to date (Strobel and Daisy, 2003). Endophytes can colonize in the stem, roots, petioles,
leaf segments, inflorescences of weeds, fruit, buds, seeds and also dead and hollow hyaline cells of
plants (Hata and Sone, 2008; Specian et al., 2012; Ste˛pniewska and Kuzniar, 2013). The population
of endophytes in a plant species is highly variable and depends on various components, such as
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host species, host developmental stage, inoculum density and
environmental condition (Dudeja and Giri, 2014).
However, very few studies have exploited these symbiotic
groups of organisms and their bioactive metabolites. For the
past few decades, it has become evident that the discovery
rate of active novel chemical entities is declining. While plant
sources are being extensively explored for the discovery of new
chemical entities for various therapeutic purposes, endophytic
microorganisms play an important role in this search for natural
bioactive compounds, with potential use in the health sector and
in drug discovery (Lam, 2007). This review highlights the various
sources of endophytes, their secondary metabolites and role as
source of drugs. Such studies may improve the understanding of
endophytes and address the need for new and useful compounds
necessary to combat various pathogens associated with human
health and other possible medicinal uses.
WHAT IS AN ENDOPHYTE?
Numerous surveys, mostly on the pathogenicity interactions
between plants and microorganisms associated with them, have
been accomplished. However, after several explanations and
studies on the role of microbial diversity associated with various
plant species, it was assumed that only a small fraction of the
microbes interacting with the plant are pathogenic in nature
(Andreote et al., 2014). Most of the microorganisms that inhabit
plants play a major role in the plant’s health and development,
although, sometimes they are neutral (Mendes et al., 2013;
Philippot et al., 2013). It is considered that a single plant species
could possess thousands of microbes, categorized as epiphytes
(microbial inhabitants of the rhizosphere and phyllosphere; those
near or on plant tissue) or endophytes (microbes residing within
plant tissues in leaves, roots or stems), depending on their area
of colonization in the plant species (Oldroyd et al., 2011; Turner
et al., 2013; Andreote et al., 2014).
Apart from the disease-causing microorganisms, the presence
of other (non-pathogenic) organisms inside the plants was first
pronounced by De Bary (1866), who detected the presence of
microbial cells in the microscopically analyzed plant tissues.
However, this observation continued to be unexplored until the
definition of endophytes came into existence toward the end
of last century. De Bary (1866) provided the first definition of
an endophyte, as “any organism that grows within plant tissues
are termed as endophytes,” however, the definition continues
to change as per various researchers (Wilson, 1995; Hallmann
et al., 1997; Bacon and White, 2000). Petrini (1991) provided
the most suitable definition for endophytes, which means any
organism that at some part of its life cycle, colonizes the internal
plant tissues without causing any type of harm to the host
plant. Furthermore, due to extensive studies of these groups of
microorganisms, the endophytic communities have been divided
into different subgroups, such as ‘obligate’ or ‘facultative,’ which
are associated with all types of plants (Rosenblueth and Martínez-
Romero, 2006). Endophytes that depend on the metabolism of
plants for survival, being spread amongst plants by the activity
of different types of vectors or by vertical transmission, are
termed obligate endophytes (Hardoim et al., 2008). Whereas,
the facultative endophytes are those that live outside the host
body during a certain stage of their life cycle and are mostly
associated with plants from its neighboring soil environment and
atmosphere (Abreu-Tarazi et al., 2010).
Numerous attempts have been made during recent years
to discover the origin of endophytic organisms in different
species (Hallmann et al., 1997; Mitter et al., 2013). Initially,
researchers choose the rhizosphere or the seed-born microbial
communities as the major sources of endophytes. Normally, the
specific endophytes interaction with various plants and evidence
of their strategy of existence and transmission is provided by
their genome organization (Andreote et al., 2014). Researchers
have reviewed the genome sizes and origins of endophytes by
correlating the genome size with the bacterial lifestyle (Dini-
Andreote et al., 2012). As per many researchers, the definition
of endophytes could be suitable for the hypothesis that they
live inside the plant species, where the environment is more
stable compared to the soil, where the plant grows. However,
there are also some endophytes that only appear in the plant
during part of their lifecycle. Thus, the endophytic community
is made up of organisms from distinct origins, with those with
larger genomes likely to live in variable environments, such as
soils, while those with smaller genomes are likely to exist in the
stable environment and are vertically transmitted (Mitter et al.,
2013).
TYPES OF ENDOPHYTES
Endophytes are associated with plants in various forms, including
bacteria (actinomycetes or mycoplasma) or fungi that have
been colonized inside the plant tissues. More than 200 genera
from 16 phyla of bacterial species have been reported to be
associated with endophytes and among them, most of the
species belong to the phyla Actinobacteria, Proteobacteria, and
Firmicutes (Golinska et al., 2015). The diversity of endophytic
bacteria ranges from gram-positive to gram-negative bacteria,
such as Achromobacter, Acinetobacter, Agrobacterium, Bacillus,
Brevibacterium, Microbacterium, Pseudomonas, Xanthomonas
etc. (Sun et al., 2013). Bacterial endophytes are diverse in nature
and are known to produce different bioactive metabolites that act
as antimicrobial and anticancer compounds, for example, with
76% of them reported from the single genus, Streptomyces (Berdy,
2012).
Actinomycetes are prokaryotic microorganisms that belong
to the phylum Actinobacteria and possess mycelium like fungus
and forms spores (Chaudhary et al., 2013; Barka et al., 2016).
Traditionally, these actinomycetes were considered transitional
forms between the fungi and bacteria (Barka et al., 2016).
However, the comparison of actinomycetes to fungi is only
superficial because most of their properties are similar to those
of bacteria but unlike bacterial cells, the cells of actinomycetes
are thin with a chromosome that is organized in a prokaryotic
nucleoid and a peptidoglycan cell wall. Endophytic actinomycetes
are known to produce various chemical entities with unique
structures of considerable medicinal importance (Gayathri
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and Muralikrishnan, 2013; Singh and Dubey, 2015). Many
antimicrobial compounds have been reported from various
types of endophytic actinomycetes. Streptomyces is one of
the dominant genera, which is most commonly isolated as
endophytic actinomycetes (Zhao K. et al., 2011; Golinska
et al., 2015). Compounds of biological interest isolated from
Streptomyces sp. include munumbicins (A and B), naphthomycin
(A and K), clethramycin, coronamycin, cedarmycin (A and
B), saadamycin, and kakadumycins. Other active compounds
isolated from actinomycetes are paclitaxel extracted from
Kitasatospora sp. associated with Taxus baccata, and tyrosol from
Emblica officinalis, which is suggested to inhibit food-borne
microbes (Zhao K. et al., 2011; Gangwar et al., 2014; Golinska
et al., 2015).
Mycoplasma species are also reported as plant endophytes.
Endophytic mycoplasma species were conveyed to be in a
symbiotic relationship with some red algae, such as Bryopsis
pennata, B. hypnoides and also in Arcobacte (Hollants et al.,
2011). However, there is no confirmed evidence of its uses, the
source of extraction or use against foodborne diseases or other
pathogens.
Fungi are a heterotrophic group of organisms with various
life cycles that include symbiotic relationships with a wide
variety of autotrophic organisms (Dayle et al., 2001). Endophytic
fungi have been classified into two broad groups based on
their phylogeny and life history traits. These include the
clavicipitaceous, which infect some grasses confined to cool
regions and the non-clavicipitaceous endophytes, which are
from asymptomatic tissues of non-vascular plants, ferns
and allies, conifers and angiosperms and are limited to the
Ascomycota or Basidiomycota group (Jalgaonwala et al., 2011;
Bhardwaj and Agrawal, 2014). Endophytic fungi produce some
of the most broadly used antibiotic and anticancer drugs.
Penicillenols, extracted from Penicillium sp., is cytotoxic
to numerous cell lines. Taxol, isolated from Taxomyces
andreanae, is the most effective and successful anticancer
drug extracted from endophytic fungi to date. Clavatol (Torreya
mairei), sordaricin (Fusarium sp.), jesterone (Pestalotiopsis
jesteri), and javanicin (Chloridium sp.) are all known to
possess strong antibacterial and antifungal properties against
numerous foodborne infectious agents (Jalgaonwala et al., 2011).
Pestacin, isolated from P. microspora, has excellent antioxidant
properties.
ISOLATION AND IDENTIFICATION OF
ENDOPHYTES FROM DIFFERENT
SOURCES
Though the endophytes were overlooked for a long time and
are considered as pathogen-causing contaminations, many that
inhabit inside the plants are often recognized as symbionts,
with a distinctive and cherished interaction with the plants
with whom they grow (Mitter et al., 2013; Berg et al., 2014).
Recent studies have confirmed the occurrence of endophytes
by various cultivation-independent assays and by fluorescence
in situ hybridization-confocal laser scanning microscopy studies
(Mitter et al., 2013; Berg et al., 2014). Cultivation-based
techniques, use the recovery and testing of isolates, whereas
cultivation-independent techniques screen for variations in the
total endophytic communities (Menpara and Chanda, 2013).
Endophytes can be easily isolated on any microbial or plant
growth, such as agar, potato dextrose agar and any nitrogen-
or carbon-containing media. The most frequent method used
to detect and enumerate endophytes involves isolation from
surface-sterilized host plant tissue. The main factors that may
regulate entophyte colonization within a plant or microbial
species, include the genotype of the plant, the growth stage of
the plant, the physiological status of the plant, the type of plant
tissues, the environmental condition of the soil in which it is
grown, the sampling season, the surface sterility, selective media
and culture conditions as well as different agricultural practices
(Gaiero et al., 2013; Golinska et al., 2015) Ecological awareness
on the role of endophytes in nature, can also provide the best
clues for targeting a particular type of endophytic bioactivity




Endophytes are reported to produce a number of bioactive
metabolites in a single plant or microbe which served as an
excellent source of drugs for treatment against various diseases
and with potential applications in agriculture, medicine, food and
cosmetics industries (Strobel and Daisy, 2003; Jalgaonwala et al.,
2011; Godstime et al., 2014; Shukla et al., 2014). These secondary
metabolites were categorized into various functional groups,
alkaloids, benzopyranones, chinones, flavonoids, phenolic acids,
quinones, steroids, saponins, tannins, terpenoids, tetralones,
xanthones, and many others (Figures 1A,B) (Schulz et al.,
2002; Strobel and Daisy, 2003; Jalgaonwala et al., 2011; Joseph
and Priya, 2011; Pimentel et al., 2011; Godstime et al.,
2014).
Extraction of metabolites from endophytes is affected
by various factors, such as the season of sample collection,
climatic condition and geographical location (Shukla et al.,
2014). However, with a revolutionary synthetic process that
has been developed during the past few years, extraction
from plants and other natural sources has now become more
feasible, efficient and convenient (Hussain et al., 2012).
The production of bioactive substances by endophytes,
has been directly associated with the evolution of the host
microorganisms, which may have incorporated genetic
information from higher plants, allowing them to better
adapt to the host plant and perform some functions, such
as protection from various types of pathogens, insects, and
grazing animals (Strobel, 2003). Some of the commonly found
secondary bioactive compounds from endophytes are described
below.
Taxol (paclitaxol), a complex diterpene alkaloid produced
by the endophyte Metarhizium anisopliae found in the bark
of Taxus tree, is one of the most promising anticancer
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FIGURE 1 | (A) Types of endophytes and the bioactive compound groups associated with them. (B) Selected bioactive compounds with medicinal importance
isolated from endophytes.
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TABLE 1 | Source of bioactive compounds from endophytes and their use against pathogenic microorganisms.
Source of endophytes Bioactive compounds
from endophytes





Munumbicins Escherichia coli Ground meats, raw or under
pasteurized milk
Golinska et al., 2015






Pseudomonas sp. Contaminated water or surgical
instruments
Jalgaonwala et al., 2011
Nithya and Muthumary, 2011
Cladosporium sp. Cardiac glycosides, phenolic
compounds
Klebsiella pneumoniae Contaminated water and aerosols Selvi and
Balagengatharathilagam, 2014
Cladosporium sp. Cardiac glycosides, phenolic
compounds




Saadamycin Campylobacter jejuni Raw or uncooked poultry and milk Dutta et al., 2014
Cytonaema sp. Cytonic acids A and B Human cytomegalovirus.
Hepatitis virus
Shellfish, berries or contaminated water Bhardwaj and Agrawal, 2014
Diaporthe helianthi Fabatin, tyrosol Enterococcus hirae Nosocomial infection through
hospitalized patients
Godstime et al., 2014
Specian et al., 2012
Fusarium proliferatum Beauvericin Clostridium botulinum Improperly processed, canned food Meca et al., 2010
Fusarium proliferatum Kakadumycin, beauvericin Listeria monocytogenes Raw or under pasteurized milk,
Smoked fish
Golinska et al., 2015






Candida albicans Contaminated sweet fruits and milk
products
Jalgaonwala et al., 2011
Dutta et al., 2014
Ganoderma boninense Rapamycin, cyclododecane,
petalostemumol
Bacillus subtilis Rice, pastas, raw milk and meat
products
Parthasarathi et al., 2012;
Ismail et al., 2014
Hypericum perforatum,
Diaporthe helianthi
Hypericin, emodin, tyrosol Salmonella sp. Meat, eggs, and untreated tree nuts Joseph and Priya, 2011
Specian et al., 2012
Nigrospora sp. Saadamycin Fusarium oxysporum Maize, cereals, groundnuts and tree
nuts
El-Gendy and El-Bondkly,






Aspergillus niger Maize, cereals, groundnuts, and tree
nuts
Jalgaonwala et al., 2011





Mycoplasm (TB) Uncooked meat, eggs or poultry Felnagle et al., 2007










Bakery and fermented products Ezra et al., 2004; Parthasarathi
et al., 2012
Streptomyces sp. Kakadumycin A, hypericin Shigella sp. Contaminated food, water and fecal
waste
Golinska et al., 2015







Staphylococcus aureus Meat, eggs and dairy products Hoffman et al., 2008
Streptomyces sp.,
Kennedia nigricans
Munumbicins Vibrio cholerae Raw or undercooked shellfish,
particularly oysters
Kumar et al., 2014
Streptomyces
tsusimaensis
Valinomycin Corona virus Food or water contaminated with
infected fecal matter
Alvin et al., 2014
Thottea grandiflora Streptomyces Bacillus cereus Uncooked meat and raw milk Joseph and Priya, 2011
Xylaria sp. dihydroxynaphthol,
glucopyranoside
Herpes virus Contaminated body fluid or saliva Pittayakhajonwut et al., 2005









Yersinia enterocolitica Swine meat and meat products, milk
and dairy products
Joseph and Priya, 2011
Meca et al., 2010
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agents developed or synthesized to date (Zhang et al., 2009;
Visalakchi and Muthumary, 2010; Jalgaonwala et al., 2011).
Camptothecin, from Nothapodytes foetida is known to have
cytotoxic and antifungal properties (Joseph and Priya, 2011;
Han and Rahman, 2012). Huperzine A (HupA), from Huperzia
serrata, can act as a cholinesterase inhibitor (Nair and
Padmavathy, 2014). Lignans, such as cathartics, emetics and
cholagogue, isolated from endophytic Podophyllum hexandrum,
are reported to act as anticancer agents (Konuklugil, 1995).
Resins, such as etoposide and teniposide extracted from
P. emodi, possess strong anticancer activity (Konuklugil, 1995).
Compounds such as oxacillin, ampicillin, catechin, gallic acid,
and cefalexin are known to possess bactericidal activities
(Akiyama et al., 2001). Terpenoids possess antineoplastic,
antibacterial, and antiviral effects as well as gastrointestinal
stimulation (Jalgaonwala et al., 2011; Godstime et al., 2014).
The endophytic fungus, Cytonaema sp., produces triterpenoid
helvolic acid with strong antibacterial activity (Kumar et al.,
2014).
MICROBIAL ENDOPHYTES AS SOURCE
OF DRUG AGAINST VARIOUS DISEASES
Infectious and parasitic diseases account for approximately
half of the deaths worldwide (Menpara and Chanda, 2013).
Although it is the generation of nano to pico drugs, natural
sources have been proven as the best source for drug discovery.
Medicinal plants and their endophytes are an important
source of precious bioactive compounds and secondary
metabolites that contribute to more than 80% of the natural
drugs available in the market (Singh and Dubey, 2015).
Endophytic microorganisms are the storehouse of novel
secondary metabolites that can serve as an excellent source of
drugs for antiarthritic, antimicrobial, anticancer, antidiabetic,
anti-insect, and immunosuppressant activities (Jalgaonwala et al.,
2011; Godstime et al., 2014). To date, only a few plants have
been investigated for their endophytic diversity and potential
to produce bioactive secondary metabolites. The discovery
of novel antimicrobial secondary metabolites and bioactive
compounds from different types of endophytic microorganisms
is an important alternative to overcome the increasing levels
of drugs resistance to various pathogenic microorganisms
(Godstime et al., 2014).
There are a number of bioactive compounds, such as
camptothecin, diosgenin, hypericin, paclitaxel, podophyllotoxin,
and vinblastine, which have been commercially produced
by different endophytic fungi present in respective plants
and they are of both agricultural as well pharmaceutical
importance (Joseph and Priya, 2011; Zhao et al., 2011a). These
compounds are analogs of various types of phytohormones,
essential oils etc. isolated from various endophytes (Zhao et al.,
2011b; Molina et al., 2012; Nicoletti and Fiorentino, 2015).
A detailed list of the endophytes isolated from various sources,
their bioactive metabolites and the uses of endophytes as a
source of medicine against various diseases is presented in
Table 1.
RECENT DEVELOPMENTS IN THE FIELD
OF MICROBIOME RESEARCH
Plant roots and the gastrointestinal system of animals
play a major role in the absorption of various nutrients
and thus harbor a large, complex and dynamic group of
microorganisms that help to degrade nutrients to more
easily absorbed forms (Ramirez-Puebla et al., 2013). The
animal gastrointestinal system is inhibited by a number of
microorganisms, starting from the archaea to the eukaryotes
along with a number of plant-associated bacteria, particularly
the endophytes (Rosenblueth and Martínez-Romero, 2006;
Parniske, 2008; Ramirez-Puebla et al., 2013). Similarly, various
soil types, moisture, plant genotypes, root lysates etc. are
the determinants of the root microbiota (Doornbos et al.,
2012).
The diversity of microorganisms in healthy humans vary
with diet, maintenance of hygiene, hormonal cycles, infections,
uptake of medicine, sexual activity, etc. (Muzny et al., 2013;
Gerber, 2014). In this context, various studies associated
with the microbiome of humans have been undertaken
during recent times. A study from the Human Microbiome
Project has also stated the role of the gut microbiome in
regulating the host circadian clock, which in mammals is
located in the brain (Leone et al., 2015). These studies
have provided evidence that a high-fat diet could alter
the microbiome circadian rhythm, thereby suggesting a link
between the diet, gut microbiota and obesity (Leone et al.,
2015).
Furthermore, there are a number of microbiome studies
undertaken to find out the associations and diversity of
microbiota in both plant and animal systems. Longitudinal
microbiome studies are undertaken to gain insights into the
dynamic behaviors of the microbiota, such as the microbial
succession events during maturation of the infant’s gut, normal
temporal inconsistency in healthy adults, responses to various
dietary changes and the use of different antibiotics and in
instances of dysbiotic alterations that signal symptomatic
diseases. Furthermore, the multi-omic analyses that combine
information from multiple data sources, such as metabolomes,
proteomes and transcriptomes, provide a deep vision into
the purposeful changes of the internal microbiome with
respect to time. Similarly, the computational tools to analyze
microbiome time-series data is another area that shows
tremendous growth. These techniques could model the
inter-individual variability, while automatically capturing
commonalities at appropriate levels in the ecosystems (Gerber,
2014).
CONCLUSION
Endophytes are a poorly investigated group of microorganisms
capable of synthesizing bioactive compounds that can be used
to combat numerous pathogens. These have been dependable
sources of bioactive and chemically novel compounds and have
proven to be useful for novel drug discovery. Biotransformation
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methods have a wide range of uses, particularly in the
production of numerous bioactive compounds, as antimicrobial
(vanillin, essential oils), antifungal and antiviral (alkaloids),
antioxidant(eugenol), antiinflammatory (cineole) etc. It is
imperative to review and highlight the previous successes, on-
going research and latest developments in research associated
with endophytic microorganisms to draw the attention of the
research community toward this emerging field and possible
exploitation of the available sources for their therapeutic uses
in various fields, such as the medical, pharmaceutical, food and
cosmetics.
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